Skip to Content

Palivizumab

In the US, Palivizumab (palivizumab systemic) is a member of the drug class immune globulins and is used to treat Respiratory Syncytial Virus.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J06BB,J06BB16

CAS registry number (Chemical Abstracts Service)

0188039-54-5

Therapeutic Categories

Antiviral agent

Immunomodulator

Monoclonal antibody

Chemical Name

Immunoglobulin G 1 (human-mouse monoclonal MEDI-493 gamma1-chain anti-respiratory syncytial virus protein F), disulfide wit human-mouse monoclonal MEDI-493 kappa-chain, dimer (WHO)

Foreign Names

  • Palivizumabum (Latin)
  • Palivizumab (German)
  • Palivizumab (French)
  • Palivizumab (Spanish)

Generic Names

Brand Names

  • Abbosynagis
    ABBVIE BIOPHARMACEUTICALS, Israel
  • Synagis
    Abbott, Argentina; Abbott, Australia; Abbott, Brazil; Abbott, Czech Republic; Abbott, Ecuador; Abbott, Georgia; Abbott, Oman; Abbott, Romania; Abbott, Serbia; Abbott, Slovakia; Abbott, Tunisia; Abbott, Taiwan; Abbott, South Africa; Abbott Laboratories de Chile, Chile; AbbVie, Austria; AbbVie, Belgium; AbbVie, Canada; AbbVie, Switzerland; AbbVie, Germany; AbbVie, Denmark; AbbVie, France; AbbVie, United Kingdom; AbbVie, Greece; AbbVie, Hong Kong; AbbVie, Croatia (Hrvatska); AbbVie, Hungary; AbbVie, Ireland; AbbVie, Italy; AbbVie, Japan; AbbVie, Latvia; AbbVie, Netherlands; AbbVie, Norway; AbbVie, New Zealand; AbbVie, Sweden; AbbVie, Singapore; AbbVie, Slovenia; AbbVie, Tunisia; AbbVie, Turkey; Abbvie Farmacéuticos, Mexico; AbbVie Inc., Bosnia & Herzegowina; AbbVie Polska, Poland; MedImmune, United States; Abbott Laboratories, Lithuania

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide